Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Standardize timing windows: If one dose is scheduled for morning administration, define what morning means operationally in your lab
This targeted substitution provides profound DPP-4 resistance against the primary serine exopeptidase responsible for the rapid inactivation of incretin hormones
Check your injection pen
Key specifications: Quantity: 50mg per vial Form: Lyophilised powder (unless stated otherwise) Appearance: White/offwhite (typical) Storage: Store cold, dry, protected from light/moisture (confirm per label/COA) Documentation: COA / SDS / lot number (where available) Intended use: Nonclinical laboratory research only
Additional benefits: Improves cardiovascular health, protects the kidneys, improves sleep apnea and lowers the risk of certain obesity-related cancers
US$ 21.51
US$ 21.96
US$ 29.26
US$ 24.02
US$ 20.44
